These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8098765)

  • 1. NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.
    Clissold DB; Pontecorvo MJ; Jones BE; Abreu ME; Karbon EW; Erickson RH; Natalie KJ; Borosky S; Hartman T; Mansbach RS
    J Pharmacol Exp Ther; 1993 May; 265(2):876-86. PubMed ID: 8098765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine.
    Witkin JM; Terry P; Menkel M; Hickey P; Pontecorvo M; Ferkany J; Katz JL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):473-82. PubMed ID: 8355185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
    Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
    J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
    Cook L; Tam SW; Rohrbach KW
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1159-66. PubMed ID: 1361571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs.
    Lang A; Vasar E; Soosaar A; Harro J
    Pharmacol Toxicol; 1992 Aug; 71(2):132-8. PubMed ID: 1332017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
    Akhtar M; Uma Devi P; Ali A; Pillai KK; Vohora D
    Fundam Clin Pharmacol; 2006 Aug; 20(4):373-8. PubMed ID: 16867021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
    Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMY-14802, a sigma ligand and potential antipsychotic drug, reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats.
    Wang Z; Haracz JL; Rebec GV
    Synapse; 1992 Dec; 12(4):312-21. PubMed ID: 1361249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
    Takahashi S; Sonehara K; Takagi K; Miwa T; Horikomi K; Mita N; Nagase H; Iizuka K; Sakai K
    Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NPC16377, a potent and selective sigma receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat.
    Shepard PD; Lehmann H; Connelly ST
    Eur J Pharmacol; 1994 Nov; 265(3):141-9. PubMed ID: 7875229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.
    Sorensen SM; Kehne JH; Fadayel GM; Humphreys TM; Ketteler HJ; Sullivan CK; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1993 Aug; 266(2):684-91. PubMed ID: 8102646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents.
    Lang A; Soosaar A; Kõks S; Volke V; Bourin M; Bradwejn J; Vasar E
    Pharmacol Toxicol; 1994; 75(3-4):222-7. PubMed ID: 7800667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.
    Tang AH; Franklin SR; Himes CS; Smith MW; Tenbrink RE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):440-7. PubMed ID: 9103528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
    Morimoto T; Hashimoto K; Yasumatsu H; Tanaka H; Fujimura M; Kuriyama M; Kimura K; Takehara S; Yamagami K
    Neuropsychopharmacology; 2002 Apr; 26(4):456-67. PubMed ID: 11927170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.